Applied DNA Sciences (NASDAQ:APDN )

BRIEF

published on 12/18/2024 at 15:05, 3 days ago

Linea DNA d'Applied DNA obtient l'approbation pour un essai clinique sur la thérapie par cellules CAR-T

Essai Clinique ADN Appliqué Ligne ADN Thérapie Par Cellules CAR-T Traitement De La LAM
BRIEF

published on 12/18/2024 at 15:05, 3 days ago

Applied DNA's Linea DNA Gains Approval for Clinical Trial in CAR T-Cell Therapy

Clinical Trial Linea DNA CAR T-cell Therapy AML Treatment Applied DNA
PRESS RELEASE

published on 12/18/2024 at 15:00, 3 days ago

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA
Regulatory approval for Phase I clinical trial of CD123-specific autologous CAR T-cell therapy by UHKT showcases Linea DNA as a rapid and cost-efficient manufacturing solution for AML treatment

Regulatory Approval Clinical Trial Linea DNA AML Treatment CAR-T Cell Therapies
BRIEF

published on 12/17/2024 at 22:10, 3 days 17 hours ago

Applied DNA Sciences publie ses résultats pour l'exercice 2024 et annonce une restructuration stratégique

Restructuration Stratégique Résultats Financiers 2024 ADN Appliqué Fabrication GMP Médicaments Génétiques
BRIEF

published on 12/17/2024 at 22:10, 3 days 17 hours ago

Applied DNA Sciences Reports FY2024 Results and Announces Strategic Restructuring

Strategic Restructuring GMP Manufacturing Applied DNA Fiscal Results 2024 Genetic Medicines
PRESS RELEASE

published on 12/17/2024 at 22:05, 3 days 17 hours ago

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines
Applied DNA Sciences, Inc. reports financial results for Q4 FY2024 and announces strategic restructuring with focus on genetic medicines. Completes GMP manufacturing facility by Jan 9, 2025

Financial Results Applied DNA Sciences Strategic Restructuring GMP Manufacturing Facility Genetic Medicines
BRIEF

published on 12/16/2024 at 16:05, 4 days 23 hours ago

Applied DNA annonce ses résultats financiers et fournit une mise à jour sur ses installations

Résultats Financiers Webcast Conférence Téléphonique ADN Appliqué Installation GMP
BRIEF

published on 12/16/2024 at 16:05, 4 days 23 hours ago

Applied DNA to Announce Financial Results and Provide Facility Update

Financial Results Conference Call Webcast Applied DNA GMP Facility
PRESS RELEASE

published on 12/16/2024 at 16:00, 4 days 23 hours ago

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Applied DNA Sciences, Inc. to release Q4 and FY 2024 financial results on Dec 17, 2024, and host conference call on Jan 9, 2025, discussing GMP manufacturing facility

Financial Results Conference Call Applied DNA Sciences PCR-based Technologies GMP Manufacturing Facility
BRIEF

published on 10/30/2024 at 12:20, 1 month 22 days ago

Applied DNA Sciences lève 6,5 millions de dollars grâce à une offre directe et un placement privé

Placement Privé Craig Hallum Offre Directe Technologies De L'ADN Bons De Souscription De Séries C Et D

1 2 ... 4

Published on 12/21/2024 at 01:30, 14 hours 11 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 14 hours 11 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 15 hours 36 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 15 hours 41 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 16 hours 11 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 14 hours 49 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 14 hours 56 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 20 hours 30 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 20 hours 45 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 21 hours 41 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 3 hours 23 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 3 hours 23 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 21 hours 41 minutes ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 21 hours 41 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 21 hours 46 minutes ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News